Merial Limited v Zoetis Services LLC

Link copied
Case Copied 67 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Merial Limited v Zoetis Services LLC [2016] APO 12

Patent Application:                   2007343130

Title:Methods of vaccine administration

Patent Applicant:  Zoetis Services LLC

Opponent:  Merial Limited

Delegate:  Dr B. Akhurst

Decision Date:  7 March 2016

Hearing Date:  9 May 2015 and 17 February 2016, in Canberra

Catchwords:  PATENTS – section 59 opposition to grant of a patent – manner of manufacture – obvious on the face of the specification – whether a statement in the description is factually incorrect – whether amendment of the description overcomes the manner of manufacture ground of opposition – manner of manufacture ground not established – novelty – no clear and unmistakable directions to the claimed combination of features – lack of novelty not established – inventive step – the claims lack an inventive step – utility – lack of utility not established  

Representation:  Patent applicant: Patrick Flynn of Counsel, instructed by Tony Shaw, patent attorney of Allens Patent & Trade Mark Attorneys, Sydney.

Opponent: In May 2015, Dr Jenny Petering and Dr Karen Innes, patent attorneys of FB Rice, Melbourne.  In February 2016, Jonathon Gottschall, barrister, instructed by Dr Jenny Petering and Dr Karen Innes.  

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2007343130

Title:Methods of vaccine administration

Patent Applicant:  Zoetis Services LLC

Date of Decision:  7 March 2016

DECISION

Claims 1-20 lack an inventive step. 

Zoetis has 2 months from the date of this decision to propose amendments to the claims.  

Costs are awarded according to Schedule 8 against Zoetis Services LLC.

REASONS FOR DECISION

Background

  1. Patent application 2007343130 was filed by Pfizer Products Inc. on 23 November 2007, via the PCT, claiming priority from application US 60/877332 filed on 27 December 2006.  After examination, acceptance of the application was advertised on 20 December 2012.  Changes of ownership first to Zoetis P LLC then Zoetis Services LLC (collectively Zoetis) were published on 27 June 2013 and 16 July 2015, respectively. 

  2. Merial Limited (Merial) served a notice of opposition on 20 March 2013 and filed a statement of grounds and particulars (SGP) on 20 June 2013.  Amendments to the SGP were allowed on 5 December 2013 and 16 June 2014.  Evidence in support was completed on 20 September 2013, evidence in answer on 20 February 2014 and evidence in reply on 20 May 2014.  A request by Zoetis on 11 August 2014 for leave to serve further evidence under reg. 5.10(4) was granted unopposed on 10 September 2014.  Merial filed responding evidence on 9 October 2014.  

  3. The opposition to grant of a patent was heard on 11 May 2015 in Canberra (the 2015 hearing).  Merial opposed a request by Zoetis at the hearing for further evidence under reg. 5.10(4) in order to address the manner of manufacture ground of opposition.  The matter was heard and on 7 July 2015, I granted leave to Zoetis to file the evidence.  After a request by Merial, the Commissioner issued a Notice under s 210(1)(c) requiring the production of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Merial Limited v Zoetis Services LLC and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2016] APO 12
Decision Date

CaseChat Overview and Summary

Merial Limited opposed the grant of patent application 2007343130 to Zoetis Services LLC on various grounds including lack of inventive step. The delegate of the Commissioner of Patents, Dr Barbara Akhurst, heard the opposition on 9 May 2015 and 17 February 2016. Dr Akhurst found that claims 1 to 20 of the patent lacked an inventive step. The parties had the opportunity to propose amendments to the claims. Costs were awarded according to Schedule 8 against Zoetis Services LLC. This decision is of interest to patent attorneys and lawyers advising clients on patent matters. The decision provides guidance on the construction of patent claims and the requirements for patentability in Australia. The court found that the claims defined a method of treating a dog for canine diseases by administering a therapeutically effective amount of a vaccine in 2-3 doses followed by annual dose(s), either all orally or in a combination of subcutaneous then oral doses. The court found that the claims did not define a manner of manufacture, were novel and met the requirements for utility. However, the court found that the claims lacked an inventive step in light of prior art documents including WO'115, WO'139 and Baer. The court found that, in all the circumstances, the person skilled in the art would directly be led as a matter of course to try administering the vaccines according to a route and schedule set out in at least opposed claims 1 or 2, with a reasonable expectation that it might well provide an alternative and more convenient administration regimen.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.